Sutro Biopharma
Price & Volume
Stats
See more52W Range | $5.23-$26.54 |
Market Cap | $393.9M |
Shares Short | 532,614 |
Financials
See moreRevenue (12 Mos) | $102.4M |
Revenue Growth (YoY) | -21.4% |
Gross Profit (12 Mos) | -$63.9M |
Diluted EPS | -$22.49 |
News
See moreYahoo Finance • 2 months ago
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Yahoo Finance • 4 months ago
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance • 4 months ago
Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors
Yahoo Finance • 5 months ago
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
About
CEO | Ms. Jane Chung R.Ph. |
Address | 111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 137 |
